Daily non-political popular news in brief.
White blood cell booster may help cancer patients avoid deadly complications
07-25-2007 · EurekAlert!Cancer patients who receive a drug that stimulates the growth of infection-fighting white blood cells may be significantly less likely to die from a chemotherapy-related complication characterized by fever and low white blood cell levels, according to a multi-institutional study led by researchers from the University of Rochester School of Medicine and Dentistry and the Duke University Comprehensive Cancer Center.
Read more »
Keywords: white, blood, cell, booster, cancer, patients, avoid, deadly, complications, patient, complication
« Previous | Next »
Similar news on "White blood cell booster may help cancer patients avoid deadly complications":
- T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells
09-18-2007 · EurekAlert!
Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia, according to researchers at Memorial Sloan-Kettering Cancer Center. By administering repeated doses of T cells designed to express an artificial receptor which recognizes human B cells, the researchers were able to eradicate cancer in 44 percent of mice bearing human ALL tumors.
Similar news · Read more »
- New drug therapy to combat GVHD in stem-cell patients shows significant reduction in deaths
01-23-2007 · EurekAlert!
Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. Now, new research from Fred Hutchinson Cancer Research Center shows that adding a widely used topical corticosteroid to the standard treatment for GVHD kept the disease in remission and significantly reduces deaths one year after therapy.
Similar news · Read more »
- Pre-treatment blood test could guide lung cancer therapy
06-05-2007 · EurekAlert!
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
Similar news · Read more »
- A faster way to recover from chemotherapy and marrow transplant
06-20-2007 · EurekAlert!
Researchers at Children's Hospital Boston report finding a practical way to increase stem cells in blood, suggesting a possible treatment to help patients recover from chemotherapy or bone marrow transplant for cancer, regaining immune function more quickly. The discovery, reported in the June 21 Nature and made possible through high-volume drug screening in fish, marks the first time stem-cell production has been induced by a small-molecule drug.
Similar news · Read more »
- St. Jude researchers identify key genetic trigger of acute myeloid leukemia
11-26-2007 · EurekAlert!
A gene called N-Myc leads a double life in certain white blood cells, helping to trigger a cancer called acute myeloid leukemia (AML) under some conditions while triggering apoptosis, or cell suicide, under other conditions, according to results of a mouse study done by investigators at St. Jude Children's Research Hospital.
Similar news · Read more »
- Common blood test can help distinguish between mononucleosis and tonsillitis
01-15-2007 · EurekAlert!
Measuring a patient's ratio of white blood cell types may help physicians accurately distinguish between the similar conditions infectious mononucleosis and bacterial tonsillitis, potentially guiding treatment decisions, according to an article in the January issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.
Similar news · Read more »
- Cancer drug can extend survival in patients with deadly brain tumors
02-20-2007 · EurekAlert!
Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.
Similar news · Read more »
- New choices for patients: Transfusion-free medicine for Jehovah's Witnesses and transfusion-wary
12-05-2007 · EurekAlert!
Transfusion-free Medicine for Jehovah's Witnesses and Patients Wary of Blood Transfusions was pioneered at Pennsylvania Hospital Center for Bloodless Medicine and Surgery in Philadelphia. Bloodless medicine practices have shown outcomes that can benefit the entire patient community, including shorter hospital stays, and the elimination of transfusion-related complications. Pennsylvania Hospital is part of the University of Pennsylvania Health System.
Similar news · Read more »
- Exercise Helps Breast Cancer Patients Avoid Anemia
10-09-2006 · ScienceDaily
Women undergoing radiation treatment for breast cancer benefit from moderate intensity, regular aerobic activity, according to a new study. The study found that exercise improved the oxygen capacity of patients and maintained levels of red blood cells during radiation treatment.
Similar news · Read more »
- U of M researchers discover a pathway to turn off immune system cells
01-31-2008 · EurekAlert!
University of Minnesota researchers have discovered a new way to turn genes off in human T cells, a type of white blood cell that helps the immune system fight infections.Turning off genes, through a process known as mRNA decay, is important for regulating the body's immune response after fighting infection. This research could lead to development of new drugs that turn off the immune system in patients with autoimmune diseases -- such as rheumatoid arthritis and lupus.
Similar news · Read more »
